Diabetic retinopathy
137 results
1 - 100
Pentoxifylline for diabetic retinopathy
Diabetic retinopathy - Fenofibrate for diabetic retinopathy
- Proliferative diabetic retinopathy - Image
- Blood pressure control for diabetic retinopathy
- Aspirin in diabetic retinopathy
- Diabetic retinopathy during pregancy - Image
- Laser photocoagulation for proliferative diabetic retinopathy
- Severe nonproliferative diabetic retinopathy - Image
- Telemedicine for diabetic retinopathy screening
- Single herbal medicine for diabetic retinopathy
- Impact of diabetic retinopathy screening
- Diabetic retinopathy with neovascularisation - Image
- Typical findings of diabetic retinopathy - Image
- Laser photocoagulation for diabetic retinopathy
- Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy
- Diabetic retinopathy: neovascularisation and a microinfarction - Image
- Screening and monitoring tests for diabetic retinopathy
- Pain control during panretinal photocoagulation for diabetic retinopathy
- Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
- Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy
- Bevacizumab to prevent haemorrhage after vitrectomy for proliferative diabetic retinopathy
- Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy
- Different lasers and techniques for proliferative diabetic retinopathy
- Interventions to increase attendance for diabetic retinopathy screening
- Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy
Semaglutide is not associated with an increased risk of diabetic retinopathy; its risk association with NAION is inconclusive- Anti‐vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy
- Comprehensive treatment and follow-up of type 2 diabetes
- Central retinal artery occlusion
- Tight blood sugar control or fibrates prevent retinopathy progression but not visual loss (ACCORD)
- Topical non‐steroidal anti‐inflammatory agents for diabetic cystoid macular oedema
- Vitreous haemorrhage (VH)
- Glycaemic control for slowing the progression of microvascular complications in diabetes mellitus
- Fibrates for primary prevention of cardiovascular disease events
- Monotherapy laser photocoagulation for diabetic macular oedema
- Oral antidiabetic drugs and GLP-1 analogues
- Fenofibrate reduces laser photocoagulation (FIELD)
- Anti‐vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema
- Impaired vision
- Eye symptoms and signs of systemic diseases
- Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis
- Association of glycaemic control and complications of type 2 diabetes
- Monotherapy laser photocoagulation for diabetic macular oedema
- Age-related macular degeneration (AMD)
- Diabetic kidney disease (diabetic nephropathy)
- Retinal venous thrombosis
- Orbital radiotherapy for adult thyroid eye disease
- Retinal detachment
- Follow-up of type 1 diabetes